Cellares logo

Cellares Funding & Investors

Cellares is revolutionizing cell therapy manufacturing. Cellares is developing a one-of-a-kind solution, The Cell Shuttle, to overcome the challenges associated with manufacturing so these life-saving therapies are affordable and widely available to patients who can benefit.


Total Amount Raised: $355,000,000

Cellares Funding Rounds

  • Series C


    Series C Investors

    Koch Disruptive Technologies
    Willett Advisors
    Decheng Capital
    Bristol-Myers Squibb
    DFJ Growth
    8 | partners
    Eclipse Ventures
  • Series B


    Series B Investors

    Decheng Capital
    Eclipse Ventures
    8 | partners
    Skyviews Life Science
  • Series A


    Series A Investors

    Eclipse Ventures
    8 | partners
    EcoR1 Capital
Funding info provided by Diffbot.